ERYTECH to Present at Jefferies 2019 HealthCare Conference in London

ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil Beyen, Chief Executive Officer of ERYTECH, is scheduled to present at the Jefferies 2019 Healthcare Conference in London on November 20, 2019. The presentation starts at 4:40 p.m. GMT/11:40 a.m. EST and will be webcast.

To access the live webcast, visit the “Investors” section of the ERYTECH website: www.erytech.com/investors/webcast/ and via the below link: wsw.com/webcast/jeff123/eryp/

Following the live webcast, an archive of the presentation will be available on the company website for 90 days, under the “Investors” section at investors.erytech.com.

ERYTECH to Host Third Quarter 2019 Conference Call and Business Update on November 8, 2019

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a Third Quarter 2019 conference call and webcast on Friday, November 8, 2019, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 7394954#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/irt7vk6s

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 7394954#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

ERYTECH to Host Second Quarter 2019 Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its second quarter 2019 conference call and webcast on Wednesday, September 18, 2019, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 1396310#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/fjhy9qqr

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 1396310#. An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

ERYTECH to Host on May 7, 2019 First Quarter Conference Call and Business Update at 2:30 PM CET/8:30 AM EST

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its 2019 first quarter conference call and webcast on Tuesday, May 7, 2019, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 2199912#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/t9xnoz52

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 2199912#. An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

Conference call on Tuesday, March 12 at 1:30 pm CET/8:30 am EST

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fourth quarter and full year 2018 conference call and webcast on Tuesday, March 12, 2019, at 1:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 3291426#:

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 76 74 89 88
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/bdbuhozf

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 3291426#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

Conference call on Tuesday, November 13 at 2:30 pm CEST/8:30 am EST

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a Third Quarter 2018 conference call and webcast on Tuesday, November 13, 2018, at 2:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 9487808#:

  • USA/Canada: +1 (833) 818-6807
  • France: +33 176748988
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/kx3a3zti

An archived replay of the call will be available for 7 days by dialing + 1 800 585 8367, Conference ID: 9487808#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

WEBCAST Wednesday, November 7th at 8:00 AM ET/ 12:00 CET

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced a KOL breakfast on Wednesday, November 7, 2018 from 8:00 A.M. – 11:00 A.M. ET in New York City.

An archived version will be available within approximately two hours of the live presentation and can be accessed at the same location for 60 days.

>> Link to slideshow

WEBCAST Thursday, September 13th at 4:40 PM EDT

Lyon (France), September 13, 2018 – ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating drug substances inside red blood cells, today announced that Gil Beyen will present and host investor meetings at the 2018 Morgan Stanley Global Healthcare Conference.

An archived version will be available within approximately two hours of the live presentation and can be accessed at the same location for 60 days.

Conference call on Tuesday, September 11th at 2:30 pm CEST/8:30 am EST

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host a second quarter 2018 conference call and webcast on Tuesday, September 11, 2018, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

Conference Details:

  • Webcast Date: September 11th, 2018
  • Presentation Time: 2:30 pm CEST/8:30 am EST

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 4983808#:

USA/Canada: +1 (833) 818-6807
France: +33 176748988
United-Kingdom: +44 2031070289
International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/m6/p/z452iwaf.

An archived replay of the call will be available for 7 days by dialing + 1 800 585 8367, Conference ID: 4983808#. An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at https://investors.erytech.com.

Link to slideshow

Menu